Spread the love“`html When you’re developing location-aware mobile applications, whether for Android or other platforms, ...
Patients with early relapsing multiple sclerosis (MS) were able to switch to ocrelizumab after suboptimal responses to other disease-modifying therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results